“…10 Alterations of P-wave duration have been studied in several clinical settings, such as idiopathic PAF, ischemic heart diseases, after coronary artery bypass surgery, hypertension, and congestive heart failure. [11][12][13][14][15][16] Recently, P-wave dispersion (Pd) has been proposed to be a useful index for identifying the risk for AF in several clinical conditions. 11,15 Thus, in the present study, we investigated whether Pd could be used to discriminate between patients with HCM with and without a history of PAF.…”